1,991
Views
22
CrossRef citations to date
0
Altmetric
Articles

The History of MDMA as an Underground Drug in the United States, 1960–1979

, M.D., M.A. & , M.D., Ph.D.
Pages 67-75 | Received 29 Jun 2015, Accepted 26 Oct 2015, Published online: 03 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Anne C. Wagner, Michael C. Mithoefer, Ann T. Mithoefer & Candice M. Monson. (2019) Combining Cognitive-Behavioral Conjoint Therapy for PTSD with 3,4-Methylenedioxymethamphetamine (MDMA): A Case Example. Journal of Psychoactive Drugs 51:2, pages 166-173.
Read now
Khary K. Rigg & Amanda Sharp. (2018) Deaths related to MDMA (ecstasy/molly): Prevalence, root causes, and harm reduction interventions. Journal of Substance Use 23:4, pages 345-352.
Read now

Articles from other publishers (20)

Laura Bechtold & Dimitris Repantis. (2024) MDMA-gestützte Therapie. Nervenheilkunde 43:05, pages 270-274.
Crossref
F. Dellanoce, Z. Dubus, M. Vidal, C. Vigourt & T. Rabeyron. (2024) Une nouvelle prise en charge innovante dans le traitement des troubles de stress post-traumatique : la thérapie assistée par MDMA, approche historique et analyse des protocoles actuels. Pratiques Psychologiques 30:1, pages 37-56.
Crossref
Jai Whelan, Geoffrey E. Noller & Ryan D. Ward. (2023) Rolling through TikTok : An analysis of 3,4‐methylenedioxymethamphetamine‐related content . Drug and Alcohol Review 43:1, pages 36-44.
Crossref
Kainat Riaz, Sejal Suneel, Mohammad Hamza Bin Abdul Malik, Tooba Kashif, Irfan Ullah, Abdul Waris, Marco Di Nicola, Marianna Mazza, Gabriele Sani, Giovanni Martinotti & Domenico De Berardis. (2023) MDMA-Based Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD): A Brief Narrative Overview of Current Evidence. Diseases 11:4, pages 159.
Crossref
Aaron S. Wolfgang & Charles W. Hoge. (2023) Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations. Current Psychiatry Reports 25:10, pages 513-532.
Crossref
Jaden Brandt. (2023) A roadmap for psychedelic pharmacy in Canada: A proposed policy and operations approach for controlled access to select psychedelics for treatment of mental illness. Drug Science, Policy and Law 9, pages 205032452311703.
Crossref
Raúl López-Arnau, Jordi Camarasa, Marcel·lí Carbó, Núria Nadal-Gratacós, Pol Puigseslloses, María Espinosa-Velasco, Edurne Urquizu, Elena Escubedo & David Pubill. (2022) 3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs. Frontiers in Psychiatry 13.
Crossref
Jenna M. TraynorDaniel E. RobertsStephen RossRichard ZeifmanLois Choi-Kain. (2022) MDMA-Assisted Psychotherapy for Borderline Personality Disorder. FOCUS 20:4, pages 358-367.
Crossref
Sabrina Correa da Costa, Tyler Oesterle, Teresa A. Rummans, Elliot Richelson & Mark Gold. (2022) Psychedelic drugs for psychiatric disorders. Journal of the Neurological Sciences 440, pages 120332.
Crossref
Fúlvio Rieli Mendes, Cristiane dos Santos Costa, Victor Distefano Wiltenburg, Gabriela Morales-Lima, João Ariel Bonar Fernandes & Renato Filev. (2022) Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research. Addiction Neuroscience 3, pages 100025.
Crossref
Ryan L. Henner, Matcheri S. Keshavan & Kevin P. Hill. (2022) Review of otential sychedelic reatments for PTSD. Journal of the Neurological Sciences 439, pages 120302.
Crossref
Ben Sessa, Jacob S Aday, Steve O’Brien, H Valerie Curran, Fiona Measham, Laurie Higbed & David J Nutt. (2021) Debunking the myth of ‘Blue Mondays’: No evidence of affect drop after taking clinical MDMA. Journal of Psychopharmacology 36:3, pages 360-367.
Crossref
João Paulo Capela & Félix Dias Carvalho. (2022) A review on the mitochondrial toxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA). Current Research in Toxicology 3, pages 100075.
Crossref
Michael Evans-Brown, Brendan Hughes & Roumen Sedefov. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances 3 56 .
Esther Papaseit, Magí Farré & Clara Pérez-Mañá. 2022. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions 2243 2268 .
Esther Papaseit, Magí Farré & Clara Pérez-Mañá. 2021. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions 1 26 .
Nicole S. Jones & Jeffrey H. Comparin. (2020) Interpol review of controlled substances 2016–2019. Forensic Science International: Synergy 2, pages 608-669.
Crossref
Torsten Passie. (2018) The early use of MDMA (‘Ecstasy’) in psychotherapy (1977–1985). Drug Science, Policy and Law 4, pages 205032451876744.
Crossref
Torsten Passie & Simon D. Brandt. 2018. New Psychoactive Substances. New Psychoactive Substances 69 110 .
Michael Evans-Brown & Roumen Sedefov. 2018. New Psychoactive Substances. New Psychoactive Substances 3 49 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.